“Medical” Board of Corporate Bias Targets Doctors Who Question Them | Dr. Peter McCullough

June 28, 2022

Featured image interview sylvain henry
National Referendum to End All Lockdown Measures in Canada
July Update still
Will’s July Update
Corinnas insight report still
Insight Report Interview with Corrina Fischer
Iron Will Single
video teaser
Violations of Our Charter Rights: An interview with Lawyers4Truth

Dr. Peter McCullough is board certified in internal medicine, cardiovascular diseases, and clinical lipidology.  He cares for patients with heart and kidney disease and has become an expert on treating COVID-19 illnesses. Dr. McCullough joins us to discuss recent developments in threatening his livelihood in the possible revocation of his hospital privileges as a result of his position during this PLAN-demic.  

On the threats to doctor’s livelihoods…

To clarify, the American Board of Internal Medicine credentials doctors to be Board certified in internal medicine and the specialty. So, I’ve maintained internal medicine and cardiovascular diseases board specialty certification. Now that’s different than a medical license. The medical license is granted by the states. And so, I hold a medical license in Texas. My medical license is not threatened, but my Board certifications are, and without Board certification, I can’t have hospital privileges. I can’t participate in insurance plans. Both the medical license and the Board certifications are essential to medical practice in the United States. So, my livelihood is being threatened by a contention. The Board in the letter makes the implicit assumption that the current sets of genetic biologic inoculations that are mandated in so many different walks of life, that they have an implicit presumption that they’re safe and effective.

On how the President of the Board is now Threatening via Twitter….

It started out with the presumption that there’s safety and efficacy. And then [the letter] said specifically that you made statements that drew into question the efficacy and safety of the products that could lead someone to not take one of them. So, it’s clear that their orientation is try to inject bias to actually have patients take an investigational biologic gene transfer product and like any product, there are benefits, there are risks.

LINKS:

Website: Courage to Face Covid by Dr. Peter McCullough and John Leake

Book: Courage to Face Covid

 

Recurring monthly donations only. Updated manually.